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ABSTRACT In this review, we discuss the evolution-
ary, biochemical, and functional data available for
members of the Roco protein family. They are charac-
terized by having a conserved supradomain that con-
tains a Ras-like GTPase domain, called Roc, and a
characteristic COR (C-terminal of Roc) domain. A
kinase domain and diverse regulatory and protein–
protein interaction domains are also often found in
Roco proteins. First detected in the slime mold Dictyo-
stelium discoideum, they have a broad phylogenetic
range, being present in both prokaryotes and eu-
karyotes. The functions of these proteins are diverse.
The best understood are Dictyostelium Rocos, which are
involved in cell division, chemotaxis, and development.
However, this family has received extensive attention
because mutations in one of the human Roco genes
(LRRK2) cause familial Parkinson disease. Other hu-
man Rocos are involved in epilepsy and cancer. Bio-
chemical data suggest that Roc domains are capable of
activating kinase domains intramolecularly. Interest-
ingly, some of the dominant, disease-causing mutations
in both the GTPase and kinase domains of LRRK2
increase kinase activity. Thus, Roco proteins may act as
stand-alone transduction units, performing roles that
were thought so far to require multiple proteins, as
occur in the Ras transduction pathway.—Marı´n, I., van
Egmond, W. N., van Haastert, P. J. M. The Roco
protein family: a functional perspective. FASEB J. 22,
3103–3110 (2008)
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The discovery of the Dictyostelium cyclic guanosine
monosphate (cGMP) -binding protein GbpC soon after
the genome sequence of this model organism became
available marked a new research area for cell biologists
and biochemists. GbpC was the first described member of
the Roco protein family, a group of complex proteins
found in many prokaryotes and eukaryotes. Although the
initial description of the Roco family of proteins did not
draw much attention in the field, this rapidly changed
when dominant mutations in the human Roco gene
LRRK2 were found to be involved in the development of
Parkinson disease (PD). Extensive research was then
started to elucidate the functions and biochemistry of
LRRK2 and other Roco proteins. We review here all the
available information for the genes and proteins of the
Roco family. The focus of the review is on the functions
and biochemistry of Roco proteins in Dictyostelium and
humans. The fact that at least 2 human genes, LRRK2 and
DAPK1, are involved in neurodegenerative diseases (such
as PD, Alzheimer disease, and epilepsy) and in cancer is
also discussed in detail.
CHARACTERIZATION OF THE ROCO FAMILY
First discoveries of Roco family genes
Two animal Roco genes, DAPK1 and MFHAS1 (for-
merly called “MASL1”), were discovered long ago (1,
2). However, the first data suggesting that a family with
a broad evolutionary range existed was obtained by
Goldberg et al. (3) when they characterized the gbpC
gene in the slime mold Dictyostelium discoideum. This
gene was found in bioinformatic searches for cyclic
nucleotide binding proteins. Goldberg et al. (3) found
that human and Drosophila proteins similar to GbpC
were present in the databases. Two related genes were
found in D. discoideum within a few months of that first
publication. Abysalh et al. (4) characterized the Pats1
gene in a screen for genes involved in cytokinesis, and
Abe et al. (5) detected the QkgA gene (known today also
as Roco2) in a bioinformatic search for receptor tyrosine
kinases. Both genes encoded proteins with the leucine-
rich repeats (LRRs) and the GTPase and kinase do-
mains detected in GbpC, although their structures were
somewhat simpler, because GbpC has a unique regula-
tory C-terminal region.
Definition of the Roco family: the Roc  COR
supradomain
These isolated findings were put in a broader context
when the Roco protein family was formally described by
Bosgraaf and Van Haastert (6). These researchers showed
that it was possible to define by bioinformatic analyses a
group of genes characterized by encoding products with 2
peculiar domains. The first domain, which they called
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Roc (Ras of complex proteins), was a GTPase domain
with high sequence similarity to Ras and other related
small GTPases. The second was a novel domain that they
described and called COR (C-terminal of Roc) because of
its characteristic position in all Roco proteins. By se-
quence comparisons and phylogenetic analyses, they
showed that Roc was clearly distinct from the rest of the
Ras-like GTPase domains and that the Roc and COR
domains always appeared together. Thus, the Roco family
can be defined as the group of proteins which contain the
Roc and COR domains, and the RocCOR structure can
be considered a “supradomain” (7). The initial article in
which the Roco family was described also contained a first
characterization of the domain composition of multiple
Roco proteins, which were shown to be considerably
diverse. Moreover, it was demonstrated that genes of this
family had a wide evolutionary range, being present in
both prokaryotes and eukaryotes. Four genes were de-
tected in vertebrates, which are now called LRRK1,
LRRK2, DAPK1, and MFHAS1. Strikingly, bioinformatic
searches in the Dictyostelium genome yielded 11 Roco
genes (6).
DIVERSITY OF THE ROCO FAMILY
The initial description of the Roco family opened the
door to precise analyses of the evolution and function
of Roco family genes and proteins. We now have a clear
picture of their patterns of diversification, which may
be useful to trace their functional similarities. Figure 1
shows the main subfamilies of the Roco family and
typical structures of members of each subfamily.
Prokaryotic Roco genes
As mentioned before, Bosgraaf and Van Haastert (6)
found both prokaryotic and eukaryotic Roco genes. Pro-
karyotic Rocos appear as a monophyletic group in phylo-
genetic reconstructions (8). It is unclear at present
Figure 1. Structures of Roco proteins. The tree indicates the 7 main evolutionary branches of Roco genes (8). The 11 Roco
proteins in D. discoideum are ordered according to their structural similarities, as deduced from InterProScan and comparative
sequence analyses. From top to bottom: GbpC, Pats1, Roco4, Roco7, Roco6, Roco5, Roco9, Roco10, Roco8, Roco2/QkgA, and
Roco11. To simplify the drawing, a small part of Roco9, without any domain, has been cut from its structure (white slash).
Structures for all animal, plant, and prokaryotic orthologous proteins are very similar, so only a single example of each is shown.
The animal proteins are all from Homo sapiens with the exception of MFHAS1-like, which is from Gallus gallus. Two LRRK
proteins are shown, LRRK1 (top) and LRRK2 (bottom). The plant structure corresponds to Arabidopsis thaliana TORNADO1.
Finally, the Roco prokaryotic protein shown is that of the cyanobacteria Trichodesmium erythraeum. Details for all domains but one
can be found in structural databases such as Pfam; the LRRK2-specific domains (abbreviated as LRRK2) are described in ref.
8.
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whether Roco genes originated in bacteria or if they were
horizontally transferred to prokaryotes. However, the fact
that they appear in both archaea and several distantly
related eubacterial groups (cyanobacteria, proteobacte-
ria, chlorobi, etc.) suggests an ancient origin. It is thus
possible that eukaryotic Rocos have a symbiotic, mito-
chondrial origin (8). Some bacteria species have multiple
Roco genes (e.g., Nostoc punctiforme).
Eukaryotic Roco genes
Phylogenetic analyses indicated that Roco genes have
independently diversified in animals, plants, and slime
molds. In fact, although D. discoideum Rocos and LRRK
vertebrate genes encode proteins with related kinase
domains, these domains were probably acquired inde-
pendently (8).
As we already indicated, 11 Roco genes can be
identified in the Dictyostelium genome. Surprisingly,
they are structurally more varied than the Rocos found
in all the other species together (Fig. 1). Even so, they
all contain closely related Roc, COR, and kinase do-
mains (of the TKL group) and mostly also contain
LRRs (Fig. 1) (6, 8, 9). There is good evidence for all D.
discoideum genes to have evolved quite recently by gene
duplications (8). Close inspection of the Dictyostelium
Roco genes revealed that the kinase domain of Roco10
has most likely evolved into a catalytically inactive
domain (9). The extended, peculiar C-terminal region
of GbpC was probably acquired by the fusion of a Roco
gene with a gene similar to GbpD (3).
Animals contain multiple Roco genes. Both proto-
stomes (insects, nematodes) and deuterostomes (chor-
dates, echinoderms) have LRRK and DAPK1 genes,
although MFHAS1 genes were not found in proto-
stomes (8). The diversification of Roco genes in ani-
mals is ancient: the cnidarian Nematostella vectensis con-
tains 4 LRRK genes and a MFHAS1 ortholog, although
it apparently lacks a DAPK1 ortholog (ref. 10 and
unpublished results). It is significant that, although
LRRK and DAPK1 proteins contain kinase domains
(Fig. 1), they are clearly unrelated. LRRK kinase do-
mains can be classified as belonging to the TKL group
of kinases, although DAPK1 contains a domain typical
of calcium/calmodulin-dependent kinases (6). MF-
HAS1 does not have a kinase domain. Figure 2 shows
the most parsimonious hypothesis deduced from the
available data to explain the diversification of Roco genes
in animals. Multiple duplications and losses have oc-
curred.
Some plants contain 1 or 2 Roco genes. All known
plant Roco genes are quite similar, encoding proteins
that lack kinase domains (Fig. 1) (6). As discussed later,
the only Roco gene in plants that has been studied in
detail is called TORNADO1 (TRN1, also known as
lopped) (11–13). Plant Rocos are ancient. A likely or-
tholog of TRN1 is found in the moss Physcomitrella patens
(unpublished results). In dendrograms, they form a
monophyletic group without clear relationship to any
of the animal or slime mold Roco genes (8).
FUNCTIONS OF ROCO PROTEINS
The fact that mutations in Roco genes cause diverse
human pathologies has led to a considerable interest in
understanding the functions of their proteins. The
presence of both GTPase and kinase domains in D.
discoideum and some animal Roco proteins suggested,
given its obvious parallelism with the Ras signal trans-
duction system, a role in intracellular signaling.
Functions of D. discoideum Roco proteins
From a functional point of view, D. discoideum Rocos are
the best understood. In particular, intensive research on
D. discoideum GbpC has provided the most significant
functional data in this species. GbpC is particularly inter-
esting given its involvement in chemotaxis, a process for
which Dictyostelium serves as a useful model organism.
Apart from typical Roc, COR, and kinase domains, GbpC
has an N-terminal region that contains LRRs and a
peculiar C-terminal region with a Ras guanine exchange
factor (GEF) domain, as well as GRAM, DEP, and 2
cGMP-binding domains that bind the second messenger
cGMP with high affinity (kd4 nM) (Fig. 1). Decades ago,
scientists studied a cGMP-binding protein that now ap-
pears to be GbpC (14). Finally, soon after the Dictyostelium
genome was sequenced, GbpC was identified, and a cell
line was obtained in which the gbpC gene was disrupted
(15). Analysis of this cell line confirmed earlier assump-
tions that cGMP is involved in the phosphorylation of
myosin II and its assembly in the cytoskeleton, which is
needed for proper chemotaxis. It was shown that the
phosphorylation patterns of both myosin light chain
(MLC) and myosin heavy chain (MHC) are affected after
Figure 2. Origin of the LRRK genes in animals.
The reconstruction of the evolutionary history
of these genes demonstrates that 3 of them
(LRRK1, LRRK2, and LRRK3; circles) existed
before the split between cnidarians and the rest
of the animals. The anemone Nematostella vec-
tensis currently has 4 LRRK genes, those 3 and
an additional gene (LRRK4), which seems to be
cnidarian-specific. Protostome model animal
species such as Drosophila melanogaster or Caeno-
rhabditis elegans have lost LRRK1 and LRRK2, whereas deuterostomes, including humans, have lost LRRK3. Data obtained
from refs. 8, 10.
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cAMP-stimulation of cells, a result confirmed in cells that
lack cGMP (15). Chemotaxis toward a cAMP-source is
severely affected because gbpC-null cells cannot polarize
effectively and form an abnormal amount of lateral pseu-
dopodia (16). Additional evidence for the involvement of
GbpC in myosin regulation was provided by Goldberg et
al. (17); they showed that the activation of MLCK-a, the
protein kinase that phosphorylates MLC after cAMP-
stimulation, depends on cGMP and GbpC. However, a
direct interaction between GbpC and MLCK-a or other
proteins has not yet been described, leaving the search for
a direct target of GbpC still open. More recently, a crucial
role for GbpC in chemotaxis was demonstrated: cells in
which 2 other chemotaxis signaling pathways were inhib-
ited (PI3K and PLA2) were solely dependent on the
cGMP-pathway to chemotax toward a cAMP-source (18).
Apart from myosin regulation during chemotaxis, GbpC
might also be involved in protection against osmotic stress
because some proteins have been shown to be regulated
by both high osmotic levels and cGMP. For example, the
phosphorylation state of the transcription factor StatC was
highly elevated after treatment of cells with the mem-
brane-permeable cGMP analog 8-Br-cGMP as well as by
osmotic stress (19). Similar phosphorylation patterns were
found for the protein kinase SAPK (20). These results
suggest that these proteins may lie downstream of GbpC.
Notably, Kuwayama and VanHaastert (21) found a strong
activation of guanylyl cyclases (GCs) when cells were
treated with hyperosmotic compounds, suggesting that
cGMP has a function in osmotic responses in the cell. This
activation is G-protein independent, in contrast to cAMP-
stimulated activation of GCs.
Another Dictyostelium Roco, Pats1, was found in a
screen to find novel proteins involved in cytokinesis
(4). Cells that lack the pats1 gene are large and show a
multinucleated phenotype, which becomes very evident
in cultures that are grown in suspension. During divi-
sion of these cells, MHC shows improper localization,
suggesting a role for Pats1 in directing it to the cleavage
furrow during cytokinesis. Interestingly, an interaction
between the WD40 repeats of Pats1 and the actomyosin
cytoskeleton was also found, supporting its involvement
in myosin II localization during cell division. The
protein encoded by a third D. discoideum Roco gene,
QkgA/Roco2, was disrupted to show the validity of a new
method to create knockout cell lines in Dictyostelium
(5). Cells lacking this protein show a significant in-
crease in growth rate, both in liquid medium and on
bacteria. Moreover, this protein is involved in develop-
ment; the mutants aggregate slowly and form aggrega-
tion centers that are larger than those formed by
wild-type cells, a process that eventually leads to large
slugs and culminants. From the remaining 8 Dictyoste-
lium Roco proteins, only Roco5 has been mentioned
recently in a large screen for mutants defective in the
developmental cycle (22). The roco5 null mutant was
categorized as being important in the slug and culmi-
nation stage of development. Further studies should
confirm this observation.
In summary, the current data on the described
Dictyostelium Roco proteins suggest that they are in-
volved in multiple cellular processes: they participate in
cell division, chemotaxis, and development. However,
the majority of Dictyostelium Rocos have not been de-
scribed yet; most likely, future studies will elucidate
more functions of these proteins.
Functions of mammalian Roco proteins
Dominant mutations in LRRK2 are involved in both
familial and sporadic PD (23–29) (See Fig. 3 for a
summary of mutations.) Mutations in LRRK2 may also
cause other neurodegenerative diseases (30). In hu-
mans, LRRK2 is expressed in multiple tissues, including
brain (24). Within the brain, expression appears in
multiple areas, particularly in substantia nigra (31).
This suggests a direct involvement in dopaminergic cell
death, which could be the result of mitochondria-
dependent apoptosis (32). LRRK2 interacts with the
product of another gene involved in familial PD, parkin
(33). Several other potential interactors have recently
been described (34). LRRK2 efficiently phosphorylates
moesin (35), but it is likely that its most interesting
substrates are yet uncharacterized. Recently, an associ-
ation of the LRRK2 protein with lipids has been dem-
onstrated (36, 37). It has also been shown that LRRK2
regulates neurite morphology (38).
LRRK1 is the closest relative of LRRK2 in vertebrates.
It is also expressed in the human brain (39). As we will
discuss in detail later, mutations in LRRK1 seem to be
less toxic than equivalent mutations in LRRK2 in cell
Figure 3. Missense mutations described in LRRK2 that lead to PD. Data obtained from Paisa´n-Ruı´z et al. (26).
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systems (39). So far, LRRK1 has not been found to be
involved in PD or any other human disease (40, 41).
Protostomes such as D. melanogaster or C. elegans have
single LRRK genes that are paralogs of human LRRK2
(8, 10). Sakaguchi-Nakashima et al. (42) showed that
mutations in the C. elegans LRK-1 gene generate anom-
alies in the localization of synaptic vesicle proteins. Lee
et al. (43) showed that loss of function of the LRKK
gene of D. melanogaster leads to anomalies in locomotor
activity and shrunken morphology as well as decreased
tyrosine hydroxylase staining in dopaminergic neurons
of the fly brain. However, contrary to what happens in
humans, overexpression of the gene does not produce
effects in the fly. Given that they are not true orthologs
of LRRK2, extrapolations from these protostome mod-
els to humans in order to understand the parkinsonian
phenotypes linked to LRRK2 mutations are very prob-
lematic.
DAPK1 was first discovered as involved in a mecha-
nism of cell death triggered by interferon in HeLa cells
(1). Later, it was found that the product of this gene is
a general positive regulator of cell death, both apopto-
tic and autophagic (44). DAPK1 is implicated in cancer,
given its function as a tumor suppressor by sensitizing
cells to apoptotic signals. Therefore, its expression
frequently is found diminished in tumors. In addition,
and most interestingly, it has recently been shown that
mutations that lead to reduced expression of DAPK1
contribute to heritable predisposition to chronic lym-
phocytic leukemia (45). DAPK1 may also be involved in
several pathologies involving neuronal cell death, such
as epilepsy (46) and Alzheimer disease (47). It may be
significant that the Roc domain of DAPK1 has been
shown to be a cytoskeleton-interacting domain (48).
Little is known about the function of the MFHAS1
gene. It has been found to be amplified or translocated
in different types of tumors, suggesting it has oncogenic
potential (2, 49, 50).
Roco proteins in plants
The precise functions of Roco proteins in plants are
still poorly understood. Mutations in an Arabidopsis
thaliana Roco gene, TRN1, have been described (11–13,
51). These researchers, however, did not determine
that TRN1 belongs to the Roco family but only detected
some similarity to the animal DAPK1 gene (13). TRN1
mutants have altered growth and morphogenesis and
changes in auxin distribution. TRN1 genetically interacts
with TRN2 (Tornado2), which encodes a tetraspanin (13).
Tetraspanins are integral membrane proteins involved in
many functions, including the regulation of intercellular
signaling. This has led to the hypothesis that TRN1 and
TRN2 proteins may be working together in an as yet
unknown signaling pathway (13).
BIOCHEMISTRY OF ROCO PROTEINS
The large diversity found among Roco proteins dem-
onstrates not only the importance of this family to
understand diverse cellular functions but also that
every member should be studied individually. However,
since the Roc-COR-kinase structure is identical in
LRRK2 and many other Roco proteins, biochemical
data on other Rocos may contribute to elucidate the
molecular mechanisms leading to LRRK2-dependent
PD. So far, some details of the biochemical mechanisms
involved in the activity and regulation of 3 Roco
proteins (GbpC, LRRK1, and LRRK2) are available. In
particular, research has focused on understanding the
functions and activities of separate domains of these
proteins.
Roc and kinase activities
Both GTPase and kinase activity have been demon-
strated for LRRK2. There is good evidence that the loss
of dopaminergic cells in patients with PD, resulting
from mutations in either the kinase or GTPase domains,
is caused by increased or constitutive kinase activity of
the mutated LRRK2 protein (52–56). LRRK1 also binds
GTP and has GTP-dependent kinase activity (39, 57).
Several lines of evidence suggest that activation of the
Roc GTPase domain leads to an increase in kinase
activity, which is thought to be the output action of
these proteins (39, 55–58). Some of these studies also
showed that various common LRRK2 mutations cause
an activated Roc domain and a subsequent increase in
kinase activity in vitro. In contrast, conflicting data exists
for the Parkinson-related mutations that affect the
activation loop of the kinase domain of LRRK2. Recent
studies showed a small but significant increase in kinase
activity for the commonly found G2019S and I2020T
mutations (52, 53), supporting the theory of a gain-of-
function effect of these mutations. Korr et al. (57),
however, found a decrease in kinase activity when they
created the corresponding mutations in the paralog
protein, LRRK1. In the same study, the researchers
investigated the effect of some mutations in LRRK1
corresponding to common Roc- and COR-domain mu-
tations in LRRK2. These mutations did not abolish the
ability to bind GTP, which is not surprising, because
they affect residues that are located outside the GTP-
binding pocket of the protein. In addition, Roc-stimu-
lated kinase activity was still present, but at reduced
levels, in the Roc mutant K745G (corresponding to
LRRK2-R1441G). Interestingly, the COR-domain mu-
tant was devoid of any kinase activity. These data are
still to be confirmed for LRRK2.
Because the Roc domains of LRRK1 and GbpC are
active as GTPases independently of other domains, it is
very likely that Roc activation causes increased kinase
activity instead of Roc activity being dependent on
kinase activation (ref. 56 and unpublished results). A
possible pitfall that one must keep in mind is that most
phosphorylation data on LRRK2 mutations originate
from in vitro assays, using immunoprecipitated pro-
teins. Although these assays have yielded valuable in-
formation about the effect of mutations on kinase
activities, it could be that the kinase activity is regulated
3107ROCO PROTEIN FAMILY
by proteins such as GEFs, GAPs (GTPase-activating
proteins), or heat shock proteins, which may be inac-
tive or absent in these assays, leading to misinterpreta-
tions of the effects of the mutations. Also, the use of
artificial kinase substrates could mask the real nature of
kinase activities.
Very recently, important structural information be-
came available, as the crystal structure of the Roc
domain of LRRK2 was solved (59). Previous biochemi-
cal observations suggesting that LRRK2 acts as a dimer
were confirmed in this study. Moreover, 2 residues that
suffer pathogenic mutations linked to PD (R1441 and
I1371) were shown to be involved in stabilizing dimer
formation. The PD-related mutations destabilize the
dimer structure, resulting in decreased GTPase activity,
and subsequently prolonged activation of the Roc do-
main. The likely result is an overactive kinase domain,
possibly via the action of the COR domain, which may
act as a molecular link between the Roc and kinase
domains. These data fit very well with previous obser-
vations that indicated that dominant LRRK2-associated
PD is the result of gain-of-function mutations.
Roles of other domains
It is currently not known whether the Roc domain of
LRRK2 is regulated by GEFs and/or GAPs. This infor-
mation could be essential to elucidate the effect of
many mutations on LRRK2. A recent report from Lewis
et al. (60) suggests that a mutation in LRRK2 causes
reduced GTPase activity as a result of disruption of an
interaction with a GAP. The GTPase activity of LRRK2
is in fact very low, supporting the existence of such an
interaction (58). An interesting model for understand-
ing the biochemistry of LRRK2 is provided by the
Dictyostelium protein GbpC, which itself contains a GEF
domain capable of activating its own Roc domain
(unpublished results). This supports the hypothesis of
an intramolecular GEF-Roc-kinase signaling cascade.
Strikingly, this cascade may be even further extended,
as cGMP binding to the cGMP-binding domains leads
to an activated Roc domain in vitro (unpublished
results). The importance of regulatory domains in
Roco proteins is also reflected in the observation that
GbpC proteins with inactivating mutations in various
domains show mostly decreased or abolished activity in
vivo. Figure 4 summarizes these results, leading to a
model for the intramolecular signaling cascade occur-
ring in GbpC, which is likely to be related to that
occurring in other Roco proteins. Each Roco protein,
however, may have peculiarities. For example, for
GbpC, not only are the GEF, Roc, and kinase domains
essential for its chemotactic function, but also the
GRAM domain-mediated localization to the membrane
is crucial for protein function in the cell (unpublished
results).
LRRs are present in many Roco proteins, but the
functions of these repeats are unknown. Since LRRs
were originally described as domains that mediate
protein–protein interactions, they may interact with
partners of the Roco proteins. Another possibility is
that the LRRs have a structural role for the protein
itself, perhaps supporting proper folding of the con-
served Roco core. Strikingly, a LRR-deletion mutant of
GbpC still retains cGMP-stimulated Roc activation and
proper localization, although the protein is not func-
tioning in vivo. Thus, a role for the LRR in stabilization
of the Roc or the C-terminal regulatory domains of
GbpC is unlikely (unpublished results). Ankyrin,
WD40, and other types of repeats (one of them LRRK2-
specific) are also often present in Roco proteins. They
all are probably involved in allowing protein–protein
interactions (Fig. 1). Parkinson-related mutations af-
fecting the LRRs and the LRRK2-specific repeats have
been found (Fig. 3), demonstrating their importance
for proper protein function. The effects at a molecular
level of these mutations, however, are still completely
unknown. It is very significant that no role has yet been
Figure 4. Intramolecular signaling cascade through GbpC. On binding of the second messenger cGMP to the cyclic nucleotide
binding (cNB) domains, the GEF-domain is liberated to enhance GDP/GTP exchange in the Roc domain. GTP-binding to the Roc
domain leads to an activated kinase domain, which is the output of GbpC. The GRAM domain is involved in membrane localization,
and the function of the DEP domain and LRRs are unknown, although the latter are essential for protein function in vivo.
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assigned to the characteristic COR domain, although
some mutations in this domain of LRRK2 cause PD
(Fig. 3).
FUTURE PROSPECTS
Our knowledge of Roco genes and proteins suggests
several significant lines of research that will be explored
in the next few years. A first aspect is the precise
characterization of the biochemical functions of Roco
proteins. This includes understanding the roles of their
different protein domains and how these domains
interact with each other. More crystalization data will
become available, most likely from LRRK2 but also
from other Roco proteins. They will help to elucidate
common themes in how proteins of this family function
and are regulated. Crystal structures will also be vital to
explain how mutations in LRRK2 lead to PD. These
studies should also elucidate whether the COR domain
indeed transmits Roc signals to the kinase domain, as
has been suggested.
A second research line is the characterization of the
diverse cellular functions of Roco proteins in different
organisms, from bacteria to humans. Exploration of
interaction partners, including GEFs, GAPs and pro-
teins that are directly phosphorylated by the kinase
domains, is needed. This research will lead to a better
understanding of the signaling pathways to which Roco
proteins belong and may explain why Dictyostelium uses
many more Roco proteins than other Eukaryotes. Fi-
nally, the third expected line of research is the precise
characterization of the roles of Roco proteins in hu-
mans and the understanding of their role in human
diseases. Exciting prospects will be derived from these
lines of research, which may contribute to our under-
standing of multiple cellular processes in very different
organisms.
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